Follow the people · Insider
Andrew Schwendenman
Andrew Schwendenman files insider transactions with the SEC as a chief accounting officer of Replimune Group (REPL). We hold 2 disclosed purchases and sales filed since 3 April 2024, 1 of them in the last 90 days.
- Files forREPL
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 April 2024 — 10 August 2026Chief Accounting Officer · Replimune Group (REPL)11 Form 4 lines · source: SEC Form 4
Everything they disclosed
11 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 7,632 shares of Replimune GroupSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 7,894 shares of Replimune GroupSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- was granted 36,667 shares of Replimune GroupSEC Form 47 April 2026Common Stock · traded 1 April 2026 · filed 7 April 2026
- was granted 55,000 shares of Replimune Group (a derivative holding)SEC Form 47 April 2026Employee Stock Option (right to buy) · traded 1 April 2026 · filed 7 April 2026
- was granted 10,000 shares of Replimune GroupSEC Form 419 December 2025Common Stock · traded 19 December 2025 · filed 19 December 2025
- ▼ sold on the open market 3,287 shares of Replimune GroupSEC Form 422 May 2025Common Stock · traded 20 May 2025 · filed 22 May 2025
- was granted 50,000 shares of Replimune Group (a derivative holding)SEC Form 43 April 2025Employee Stock Option (right to buy) · traded 1 April 2025 · filed 3 April 2025
- was granted 33,333 shares of Replimune GroupSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- ▼ sold on the open market 2,298 shares of Replimune GroupSEC Form 420 May 2024Common Stock · traded 16 May 2024 · filed 20 May 2024
- was granted 53,325 shares of Replimune Group (a derivative holding)SEC Form 43 April 2024Employee Stock Option (right to buy) · traded 1 April 2024 · filed 3 April 2024
- was granted 17,775 shares of Replimune GroupSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.